These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 945052)

  • 1. Behavioral effects of phenoxybenzamine administered intraventricularly in rats.
    Zebrowska-Lupina I
    Arch Immunol Ther Exp (Warsz); 1976; 24(2):223-31. PubMed ID: 945052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of central effects of noradrenaline and dopamine injected into the lateral brain ventricle in rats.
    Zebrowska-Lupina I; Malec D; Kleinrok Z
    Acta Physiol Pol; 1975; 26(3):261-74. PubMed ID: 1242288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central action of drugs acting on the cholinergic muscarinic receptor. III. Influence of atropine and scopolamine injected intraventricularly on behavior and levels of biogenic amines in the rat brain.
    Zebrowska-Lupina I; Kleinrok Z; Poddubiuk Z
    Arch Immunol Ther Exp (Warsz); 1975; 23(4):485-95. PubMed ID: 1172421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central action of drugs acting on the cholinergic muscarinic receptor. II. Influence of ecothiopate administered into the lateral cerebral ventricle on behavior in rats.
    Kleinrok Z; Wielosz M; Przegaliński E
    Arch Immunol Ther Exp (Warsz); 1975; 23(4):477-84. PubMed ID: 1172420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central neurotropic activity of homovanillic acid.
    Kleinrok Z; Zarkowski AM
    Acta Physiol Pol; 1981; 32(5):477-85. PubMed ID: 7336983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central action of adrenaline.
    Jagiełło-Wójtowicz E
    Acta Physiol Pol; 1981; 32(2):169-80. PubMed ID: 7196677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The central action of beta-adrenergic receptor blocking agents. I. The central action of intraventricularly administered isoprenaline in the rat.
    Ksiazek A; Kleinrok Z
    Pol J Pharmacol Pharm; 1974; 26(3):287-95. PubMed ID: 4859523
    [No Abstract]   [Full Text] [Related]  

  • 8. Central action of drugs acting on the cholinergic muscarinic receptor I. Influence of cholinomimetic drugs administered into the lateral cerebral ventricle on behavior in rats.
    Kleinrok Z; Wielosz M; Poddubiuk Z
    Arch Immunol Ther Exp (Warsz); 1975; 23(4):465-75. PubMed ID: 1172419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central action of 6-hydroxytryptamine in rats.
    Jamrozik-Kruk Z; Brus R
    Acta Physiol Pol; 1980; 31(3):253-60. PubMed ID: 6160727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new animal model for schizophrenia: interactions with adrenergic mechanisms.
    Borison RL; Diamond BI
    Biol Psychiatry; 1978 Apr; 13(2):217-25. PubMed ID: 208665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central action of drugs affecting beta-adrenergic receptor. II. The central action of intraventricularly applicated propranolol in rats.
    Ksiazek A; Kleinrok Z
    Pol J Pharmacol Pharm; 1974; 26(3):297-304. PubMed ID: 4859243
    [No Abstract]   [Full Text] [Related]  

  • 12. Central effects of endogenous and exogenous GABA.
    Czajka R
    Acta Physiol Pol; 1978; 29(3):193-205. PubMed ID: 707139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxical effects of d-amphetamine on behavioral thermoregulation: possible mediation by brain dopamine.
    Yehuda S; Wurtman RJ
    J Pharmacol Exp Ther; 1974 Jul; 190(1):118-22. PubMed ID: 4367895
    [No Abstract]   [Full Text] [Related]  

  • 14. Central action of phenylethylamine in rats.
    Jagiełło-Wójtowicz E
    Pol J Pharmacol Pharm; 1981; 33(1):59-71. PubMed ID: 7196039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the accumulation of p-hydroxynorephedrine in noradrenaline neurons during chronic administration of amphetamine in the rat in relation to amphetamine tolerance.
    Lewander T
    Psychiatr Neurol Neurochir; 1972; 75(3):215-8. PubMed ID: 5064647
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic lithium treatment and dopamine-mediated behavior.
    Ebstein RP; Eliashar S; Belmaker RH; Ben-Uriah Y; Yehuda S
    Biol Psychiatry; 1980 Jun; 15(3):459-67. PubMed ID: 7189675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of clozapine, thioridazine and phenoxybenzamine on the action of drugs stimulating the central catecholamine receptors.
    Maj J; Sowińska H; Baran L; Kapturkiewicz Z
    Pol J Pharmacol Pharm; 1974; 26(4):437-48. PubMed ID: 4472362
    [No Abstract]   [Full Text] [Related]  

  • 18. Interactions between agents stimulating and inhibiting the central dopamine receptors and octopamine.
    Jagiełło-Wójtowicz
    Acta Physiol Pol; 1980; 31(2):153-8. PubMed ID: 6771963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central effects of octopamine administered into the lateral ventricle of rats.
    Kleinrok Z; Jagiełło-Wójtowicz E; Szkilnik E
    Acta Physiol Pol; 1979; 30(4):445-53. PubMed ID: 228526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.